1. Do European patients with peripeheral arterial disease receive optimal lipid lowering therapy and achieve LDL-C goals? Results from the DA VINCI study. (25th November 2020) Authors: Ray, K.K; Feudjo Tepie, M; Catapano, A.L; Giovas, P; Bray, S; Masana, L; Weiss, N; Poulter, N Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Does Evolocumab use in Europe match 2019 ESC/EAS lipid guidelines? Results from the HEYMANS study. (25th November 2020) Authors: Ray, K.K; Bruckert, E; Van Hout, B; Feudjo Tepie, M; Bridges, I; Sibartie, M Journal: European heart journal Issue: Volume 41:(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗